colon cancer

Is One Cycle of Neoadjuvant Pembro OK in dMMR Colon Cancer?

by

Transforming Colon Cancer Treatment: The Impact of Pembrolizumab Recent groundbreaking findings from the RESET-C study have shown promising results for patients with deficient mismatch repair (dMMR) colon cancer, sparking significant interest in the medical community. The study revealed that a single cycle of neoadjuvant pembrolizumab might be enough to achieve a pathologic complete response in … Read more

ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer

by

Celecoxib and Circulating Tumor DNA: A New Hope in Stage III Colon Cancer Treatment Recent findings from the phase 3 CALGB (Alliance)/SWOG 80702 trial have shed light on the potential of using celecoxib to improve disease-free survival (DFS) in patients with stage III colon cancer, specifically for those with circulating tumor DNA (ctDNA) detectable in … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com